Nikkei 225 nearly wipes out virus losses with 1.1% climb at the open

NSP jumps 10% on $4.6M CEO buy, despite 35% YTD loss & high volatility. Undervalued?

LGIH drops 9% on rate hike fears; 30-yr mortgage hits 6.22%. Buy opportunity?

Generic Ozempic hits India at $14, slashing costs & reshaping the obesity market. Novo's patent loss sparks global GLP-1 race.

NEPC adds $81.88M to VTC, boosting its stake to 5.85% AUM. VTC yields 4.74% with 4.96% 1-yr return.

MTH drops 3.3% on rate fears. It's down 12% YTD, trading 29.7% below its 52-week high.

WM's 5%+ YTD gains & 31.3% EBITDA margin shine, but P/E of 34 signals high valuation.

SMCI plunges 30% on smuggling charges; valuation now 65% below 52-week high.